According to our cohort, the MPO-ANCA–positive group had more severe inflammation, higher disease activity and frequencies of renal involvement and biopsy-proven vasculitis, and the ANCA-negative group developed more cardiac manifestations and asthma. The gene discussed is MPO; the disease is asthma.